ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 131-133

  Engin, Hüseyin ^a   Bilir, Cemil ^a   Üstün, Hasan ^a   Gökmen, Ayla ^a  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

Blood group; Pancreatic cancer; Survival; Turkey

Indexed keywords

ARTICLE; BLOOD GROUP ABO SYSTEM; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TURKEY (REPUBLIC);

ABO BLOOD-GROUP SYSTEM; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TURKEY;

EID: 84864867269     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.131     Document Type: Article

References (18)

1. Amundadottir L, Kraft P, Stolzenberg Solomon RZ, et al (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90.
2. Annese V, Minervini M, Gabbrielli A, et al (1990). ABO blood groups and cancer of the pancreas. Int J Pancreatol, 6, 81-8.
3. Aird I, Bentall HH, Roberts JA(1953). A relationship between cancer of stomach and the ABO blood groups. BMJ, 1, 799-801.
4. Ben Q, Wang K, Yuan Y, Li Z (2011). Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer, 128, 1179-86.
5. Hakomori S (1999). Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta, 1473, 247-66.
6. Itzkowitz SH, Yuan M, Ferrell LD, et al (1987). Cancer-associated alterations of blood group antigen expression in the human pancreas. J Natl Cancer Inst, 79, 425-34.
7. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
8. Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol, 20, 197-209.
9. Melzer D, Perry JR, Hernandez D, et al (2008). A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet, 4, e1000072.
10. Newell GR, Gordon JE , Monlezun AP (1974). ABO blood groups and cancer. J Natl Cancer Inst, 52, 1425-30.
11. Roseman S (2001). Reflections on glycobiology. J Biol Chem, 276, 41527-42.
12. Sant M, Allemani C, Santaquilani M, et al (2009). EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer, 45, 931-91.
13. Sener SF, Fremgen A, Menck HR, et al (1999). Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg, 189, 1-7.
14. Souto JC, Almasy L, Muñiz Diaz E, et al (2000). Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol, 20, 2024-8.
15. Vioque J, Walker AM (1991). Pancreatic cancer and ABO blood types: a study of cases and controls. Med Clin, 96, 761-4.
16. Vogel F (1970). Controversy in human genetics. ABO blood groups and disease. Am J Hum Genet, 22, 464-75.
17. Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31.
18. Zhang S, Zhang HS, Cordon Cardo C, et al (1997). Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer, 73, 50-6